US$294,296
US$187,125
19.9%
US$129,706
US$46,631
US$11,515
-US$726
US$4,773
/yr
Portfolio
S&P 500 (US)
A past performer with good growth potential
14 holdings
14
Symbol | Price Vs Fair Value | 7D Return | Total Return | Value & Cost | Weight & Shares | Avg. Price | 1Y chart | |
---|---|---|---|---|---|---|---|---|
UNH UnitedHealth Group | US$271.49 68.7% undervalued intrinsic discount | 11.0% +US$536 | -33.2% -US$2,978 | US$5,430 US$8,960 | 1.8% 20 | US$448.00 | ||
BAC Bank of America | US$47.71 22.6% undervalued intrinsic discount | 6.2% +US$1,674 | 63.1% +US$12,046 | US$28,626 US$19,100 | 9.7% 600 | US$31.83 | ||
TSLA Tesla | US$335.58 167.3% overvalued intrinsic discount | 4.1% +US$1,331 | 51.8% +US$11,458 | US$33,558 US$22,100 | 11.4% 100 | US$221.00 | ||
AMZN Amazon.com | US$230.98 16.4% undervalued intrinsic discount | 3.5% +US$447 | 66.0% +US$5,479 | US$13,166 US$7,775 | 4.5% 57 | US$136.41 | ||
META Meta Platforms | US$782.13 25.9% undervalued intrinsic discount | 2.7% +US$1,726 | 353.8% +US$56,109 | US$66,481 US$13,830 | 22.6% 85 | US$162.71 | ||
JPM JPMorgan Chase | US$294.16 16.3% undervalued intrinsic discount | 2.5% +US$361 | 46.6% +US$4,893 | US$14,708 US$10,500 | 5.0% 50 | US$210.00 | ||
JNJ Johnson & Johnson | US$174.72 28.2% undervalued intrinsic discount | 1.9% +US$160 | 84.3% +US$4,300 | US$8,736 US$5,100 | 3.0% 50 | US$102.00 | ||
XOM Exxon Mobil | US$107.38 56.1% undervalued intrinsic discount | 1.3% +US$293 | 93.4% +US$12,120 | US$22,013 US$12,897 | 7.5% 205 | US$62.91 | ||
BATS British American Tobacco | UK£42.38 33.0% undervalued intrinsic discount | 1.2% +US$464 | 42.8% +US$16,488 | US$40,138 US$26,990 | 13.6% 700 | UK£30.00 | ||
NVDA NVIDIA | US$182.02 57.7% overvalued intrinsic discount | 0.7% +US$50.00 | 879.3% +US$15,258 | US$7,281 US$1,443 | 2.5% 40 | US$36.06 | ||
CRWD CrowdStrike Holdings | US$424.80 2.9% undervalued intrinsic discount | -0.05% -US$10.00 | 52.7% +US$9,545 | US$21,240 US$13,100 | 7.2% 50 | US$262.00 | ||
PLTR Palantir Technologies | US$181.00 139.0% overvalued intrinsic discount | -0.7% -US$120 | 964.7% +US$16,400 | US$18,100 US$1,700 | 6.2% 100 | US$17.00 | ||
OKTA Okta | US$88.61 31.1% undervalued intrinsic discount | -5.3% -US$398 | -55.7% -US$8,911 | US$7,089 US$16,000 | 2.4% 80 | US$200.00 | ||
TLX Telix Pharmaceuticals | AU$17.02 71.4% undervalued intrinsic discount | -6.5% -US$536 | 83.7% +US$6,129 | US$7,730 US$5,128 | 2.6% 700 | AU$11.00 |
There are three easy ways to get started:
Simply Wall St goes far beyond price tracking. You'll be able to:
Most brokers and portfolio trackers only show prices and unrealised gains, with little context and lots of noisy news. Simply Wall St offers:
In short, Simply Wall St is more than a tracker — it's a complete investing platform for monitoring, analysing, and growing your portfolio.
Have feedback on the portfolio tool?